Inhibition of major histocompatibility complex class I antigen presentation in pig and primate cells by herpes simplex virus type 1 and 2 ICP47

Journal of Virology

Volumn 72, Issue 6, 1998, Pages 5076-5084

  Jugovic, Pieter ^a,c   Hill, Ann M ^a   Tomazin, Roman ^a   Ploegh, Hidde ^b,d   Johnson, David C ^a  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

^c UNIVERSITY OF TORONTO   (Canada)

^d HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD8 ANTIGEN; IMMEDIATE EARLY PROTEIN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1;

ANIMAL CELL; ANTIGEN PRESENTATION; ANTIGEN RECOGNITION; ARTICLE; CYTOTOXIC T LYMPHOCYTE; HERPES SIMPLEX VIRUS 1; HERPES SIMPLEX VIRUS 2; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PRIMATE; PRIORITY JOURNAL; SWINE; T LYMPHOCYTE; T LYMPHOCYTE SUBPOPULATION;

EID: 0031950268     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.72.6.5076-5084.1998     Document Type: Article

References (20)

1. Ahn, K., T. H. Meyer, S. Uebel, P. Sempe, H. Djaballah, Y. Yang, P. A. Peterson, K. Fruh, and R. Tampe. 1996. Molecular mechanism and species specificity of TAP inhibition by herpes simplex virus ICP47. EMBO J. 15: 3247-3255.
2. Ahn, K., A. Gruhler, B. Galocha, T. R. Jones, E. J. Wiertz, H. L. Ploegh, P. Peterson, Y. Yang, and K. Fruh. 1997. The ER-luminal domain of the HCMV glycoprotein US6 inhibits peptide translocation by TAP. Immunity 6:613-621.
3. Fruh, K., K. Ahn, H. Djaballah, P. Sempe, P. van Endert, R. Tampe, P. Peterson, and Y. Yang. 1995. A viral inhibitor of peptide transporters for antigen presentation. Nature 375:415-418.
4. Galocha, B., A. B. Hill, R. Cook, B. Barnett, A. Nolan, A. Raimondi, D. McGeoch, and H. L. Ploegh. 1997. Identification of the active site of ICP47, an herpes simplex virus encoded inhibitor of TAP. J. Exp. Med. 185:1565-1572.
5. Goldsmith, K., W. Chen, D. C. Johnson, and R. L. Hendricks. 1998. ICP47 enhances herpes simplex virus neurovirulence by blocking the CD8+ T cell response. J. Exp. Med. 187:341-348.
6. Hanke, T., F. L. Graham, K. L. Rosenthal, and D. C. Johnson. 1991. Identification of an immunodominant cytotoxic T-lymphocyte recognition site in glycoprotein B of herpes simplex virus by using recombinant adenovirus vectors and synthetic peptides. J. Virol. 65:1177-1186.
7. Heemels, M. T., T. N. Schumacher, K. Wonigeit, and H. L. Ploegh. 1993. Peptide translocation by variants of the transporter associated with antigen processing. Science 262:2059-2063.
8. Hill, A., P. Jugovic, I. York, G. Russ, J. Bennink, J. Yewdell, H. L. Ploegh, and D. Johnson. 1995. Herpes simplex virus turns off the TAP to evade host immunity. Nature 375:411-415.
9. Hill, A. Unpublished data.
10. Johnson, D. C., and A. B. Hill. Herpesvirus evasion of the immune system. Curr. Top. Microbiol. Immunol., in press.
11. Koelle, D. M., M. A. Tigges, R. L. Burke, F. W. Symington, S. R. Riddell, H. Abbo, and L. Corey. 1993. Herpes simplex virus infection of human fibroblasts and keratinocytes inhibits recognition by cloned CD8+ cytotoxic T lymphocytes. J. Clin. Invest. 91:961-968.
12. Mavromara-Nazos, P., M. Ackermann, and B. Roizman. 1986. Construction and properties of a viable herpes simplex virus 1 recombinant lacking coding sequences of the α47 gene. J. Virol. 60:807-812.
13. Posavad, C. M., and K. L. Rosenthal. 1992. Herpes simplex virus-infected human fibroblasts are resistant to and inhibit cytotoxic T-lymphocyte activity. J. Virol. 66:6264-6272.
14. Smith, M. H., and B. H. Barber. 1990. The conformational flexibility of class I H-2 molecules as revealed by anti-peptide antibodies specific for intracytoplasmic domains: differential reactivity of S2-microglobulin "bound" and "free" H-2Kb heavy chains. Mol. Immunol. 27:169-180.
15. Tigges, M. A., S. Leng, D. C. Johnson, and R. L. Burke. 1996. Human herpes simplex virus (HSV)-specific CD8+ CTL clones recognize HSV-2-infected fibroblasts after treatment with IFN-gamma or when virion host shutoff functions are disabled. J. Immunol. 156:3901-3910.
16. Tomazin, R., A. B. Hill, P. Jugovic, I. York, P. van Endert, H. L. Ploegh, D. W. Andrews, and D. C. Johnson. 1996. Stable binding of the herpes simplex virus ICP47 protein to the peptide binding site of TAP. EMBO J. 15:3256-3266.
17. Tomazin, R., N. E. G. van Schoot, K. Goldsmith, P. Jugovic, P. Sempe, K. Fruh, and D. C. Johnson. 1998. Herpes simplex virus type 2 ICP47 inhibits human TAP but not mouse TAP. J. Virol. 72:2560-2563.
18. Walker, C. M., V. Paetku, W. E. Rawls, and K. Rosenthal. 1985. Abrogation of anti-Pinchinde virus cytotoxic T cell memory by cyclophosphamide and restoration by coinfection and interleukin 2. J. Immunol. 135:1401-1407.
19. York, I., and D. C. Johnson. Unpublished observations.
20. York, I. A., C. Roop, D. W. Andrews, S. R. Riddell, F. L. Graham, and D. C. Johnson. 1994. A cytosolic herpes simplex virus protein inhibits antigen presentation to CD8+ T lymphocytes. Cell 77:525-535.